Navigation Links
Abbott and Enanta Present Positive Initial Results from Phase 2 Study of ABT-450/r for Treatment of Hepatitis C
Date:11/1/2010

//Newsrelease id s.tl(this,'o', 'CrowdFactory_'+socialText);*/ var s=s_gi(s_account);s.linkTrackVars='prop5,eVar3,prop15,prop16,prop49,events';s.linkTrackEvents='event12';s.prop5='share it release';s.eVar3=s.prop5; s.prop15='106439393';s.prop16='CrowdFactory_'+socialText;s.prop5+='_'+s.prop16;s.prop49=s.pageName;s.events='event12';s.tl(this,'o','CrowdFactory_'+socialText); }); });  

ABBOTT PARK, Ill. and WATERTOWN, Mass., Nov. 1, 2010 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) and Enanta Pharmaceuticals today announced positive results from a Phase 2 study of ABT-450/r, an investigational, oral protease inhibitor being developed for the treatment of hepatitis C (HCV) infection.  Initial 3-day and 4-week results suggest that ABT-450/r (ABT-450 with 100mg of ritonavir to support once-daily dosing) demonstrates potent antiviral activity in treatment-naïve adults.  Results show that more than 90 percent of patients (21 of 23) on study drug achieved HCV-RNA levels <25 IU/mL at four weeks. Results were presented today at the American Association for the Study of Liver Disease annual meeting in Boston.

Key findings:  

  • After three days, treatment with ABT-450/r alone resulted in statistically significant, 4-log mean reductions of HCV RNA, across the three dose ranges of ABT-450 (50mg, 100mg, 200mg, once-daily dosing) compared to placebo  
  • At week four, 91.3 percent (21 of 23) of patients receiving ABT-450/r in combination with standard of care (SOC) – pegylated alpha interferon and ribavirin (pegIFN/RBV) – achieved HCV-RNA <25 IU/ml
  • Safety appears consistent to that expected with SOC

  • "In spite of the progress that has been made in HCV treatment, limitations in efficacy remain with the current standard of care," Fred Poordad, M.D., chief of hepatology at the Liver Disease and Transplant
    '/>"/>

    SOURCE Abbott
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

    Related medicine technology :

    1. Abbott Again Recognized for Environmental Initiatives in Illinois
    2. Abbott Statement: Abbott Provides Support for Cholera Relief Efforts in Haiti
    3. Abbott to Voluntarily Withdraw Meridia® (Sibutramine) in the U.S.
    4. Abbott Laboratories Agrees to Withdraw Its Obesity Drug Meridia
    5. Abbott Named One of the Top Employers in the Biotech and Pharmaceutical Industry by Science Magazine
    6. Abbott Receives FDA Market Clearance for Next-Generation Contact Lens Disinfecting Solution
    7. Abbotts XIENCE V® Shows Continued Strong Performance in Key Safety and Efficacy Measures at Two Years in Investigator-Initiated COMPARE Trial
    8. Abbott and Reata Pharmaceuticals Announce Agreement to Develop and Commercialize Bardoxolone Methyl for Chronic Kidney Disease Outside the U.S.
    9. Abbotts Fully Bioresorbable Vascular Scaffold Technology Continues to Demonstrate Strong Clinical Results
    10. The Deal Names Abbott Top Dealmaker for Third Consecutive Year
    11. Abbott Declares 347th Consecutive Quarterly Dividend
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/15/2014)... Dec. 12, 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/ms3j8c/cardiac ) has announced the addition of the ... 2012-2018"  report to their offering. Global Guidewires sector ... North America accounts for nearly ... Europe claims approximately 25% (2018). ...
    (Date:12/15/2014)... Washington State are not the only ... Oregon , Alaska , and ... 2014 elections. Photo - http://photos.prnewswire.com/prnh/20141212/164152 ... The benefits of legalizing cannabis are manifold. There are the ... revenue for state and local governments, in addition to reduced ...
    (Date:12/15/2014)... Colo. , Dec. 15, 2014  The Government of ... collaboration of AABB, Global Blood Fund (GBF) and Terumo BCT to ... , as well as provide long-term health system capacity to ... Facts: , The Ghanaian Ebola Readiness and Resilience Initiative ... Ghana,s preparations for the possible arrival of the ...
    Breaking Medicine Technology:Cardiac Guidewires - Global Trends, Estimates and Forecasts, 2012-2018 2Cardiac Guidewires - Global Trends, Estimates and Forecasts, 2012-2018 3Cardiac Guidewires - Global Trends, Estimates and Forecasts, 2012-2018 4CannaInsider.com Estimates 200,000 New Jobs in the Cannabis Industry by 2015 2Government of Ghana Endorses Collaboration to Combat Ebola Epidemic 2Government of Ghana Endorses Collaboration to Combat Ebola Epidemic 3Government of Ghana Endorses Collaboration to Combat Ebola Epidemic 4Government of Ghana Endorses Collaboration to Combat Ebola Epidemic 5Government of Ghana Endorses Collaboration to Combat Ebola Epidemic 6
    (Date:12/17/2014)... -- Expectant parents should leave prenatal picture-taking to medical ... Use of ultrasound imaging and heartbeat monitors to get ... agency warns. "Although there is a lack ... and heartbeat monitors, prudent use of these devices by ... FDA biomedical engineer, said in an agency news release. ...
    (Date:12/17/2014)... HealthDay Reporter , TUESDAY, Dec. 16, ... America, and work commitment is a big reason why, new ... said Dr. Mathias Basner, an assistant professor of sleep and ... of Medicine. A time-use survey of nearly 125,000 Americans, ... main activity exchanged for sleep. Short sleepers -- those who ...
    (Date:12/15/2014)... 15, 2014 South Florida’s leading urgent care ... can be a daze of hassle, hustle, and bustle that ... decking halls, to burns when making special meals and heartburn ... can happen at any time. To prevent this season of ... made a list of helpful and healthful holiday tips to ...
    (Date:12/15/2014)... News) -- Expert pilots process visual information more efficiently ... better decisions during landings, a new study shows. ... pilots to master, and 36 percent of all airplane ... final approach and landing. Researchers monitored the brain ... pilots while they were at the controls of a ...
    (Date:12/15/2014)... 15, 2014 At the leading, long-established ... AutismOne and Focus Autism will welcome ... research on the effects of toxins to children’s health, ... information. , Luminaries such as Dr. Lucija Tomljenovic ... with esteemed, credentialed colleagues of the United States to ...
    Breaking Medicine News(10 mins):Health News:FDA Warns Against Fetal 'Keepsake' Videos 2Health News:Work Steals Valuable Sleep Time, Study Finds 2Health News:Work Steals Valuable Sleep Time, Study Finds 3Health News:MD Now Urgent Care Presents Healthy Holiday Tips 2Health News:MD Now Urgent Care Presents Healthy Holiday Tips 3Health News:Study Shows Why Expert Pilots Are Experts 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 3
    ... of Directors of BD (Becton, Dickinson and Company) (NYSE: ... cents per common share, payable on March 31, 2009 to ... dividend rate is $1.32 per share. About BD ... company that develops, manufactures and sells medical devices, instrument systems ...
    ... Hosts Second Annual Corporate Philanthropy Summit , LOS ANGELES, ... today hosts its Second Annual Corporate Philanthropy Summit, an ... leaders to work with the public and nonprofit sectors ... luncheon will be Henry Cisneros, executive chairman of CityView ...
    ... common New Year,resolutions revolve around being healthier, but are ... more, and eat less junk,food. A growing collection of ... In order to become a healthier individual, people must,focus ... as well as,physical health. , ...
    ... Rate in the CaribbeanCHICAGO, Feb. 3 ... Association, is working with the government of Guyana to ... affected by HIV/AIDS in this high-need region of the ... just individuals, will provide a more secure future for ...
    ... found , , TUESDAY, Feb. 3 (HealthDay News) -- Vacations at ... deadly skin cancer melanoma later in life, a new study ... 1998 in Colorado, asking their parents about childhood vacation destinations ... 7 to look for nevi -- commonly known as moles. ...
    ... an Increasing Number of Negative Health Effects Resulting from ... 2nd year, the UV Foundation is promoting awareness of ... dubbing February "Vitamin D Deficiency Month." Vitamin D ... above the 37th parallel because it is impossible to ...
    Cached Medicine News:Health News:Local Business Leaders Assemble to Address Critical Issues Facing Los Angeles 2Health News:Local Business Leaders Assemble to Address Critical Issues Facing Los Angeles 3Health News:Dakim Recommends Six New Year Resolutions to Stay Cognitively Fit 2Health News:Chicago HIV/AIDS Organization Works with Government of Guyana to Implement New Programs to Help Children Affected by Epidemic 2Health News:Childhood Beach Vacations May Boost Melanoma Risk 2Health News:UV Foundation Announces: February is Vitamin D Deficiency Month 2
    Sheath Introducers with guidewires....
    ... Stent design, utilizing an advanced ... of stainless steel stents. This ... struts, for unparalleled flexibility plus ... Coronary Stent Systemwith thin struts ...
    ... Guiding Catheter provides support to enhance ... under adverse conditions. It gives you ... to your destination in cardiac interventions. ... variety of clinical situations and the ...
    ... Xtra, and Maximum ACT introducers represent ... specialty hemostasis introducers in the world. ... hemostasis introducers for use in interventional ... angioplasty, stenting, atherectomy, temporary pacing, endomyocardial ...
    Medicine Products: